Aurelia M Meloni-Ehrig

Summary

Affiliation: Quest Diagnostics
Country: USA

Publications

  1. ncbi Isolated del(14)(q21) in a case of precursor B-cell acute lymphoblastic leukemia
    Aurelia M Meloni-Ehrig
    Laboratory of Cytogenetics, Quest Diagnostics Nichols Institute, 14225 Newbrook Drive, Chantilly, VA 20151, USA
    Cancer Genet Cytogenet 161:82-5. 2005
  2. ncbi Translocation (2;8)(q35;q13): a recurrent abnormality in congenital embryonal rhabdomyosarcoma
    Aurelia Meloni-Ehrig
    Department of Cytogenetics, Quest Diagnostics Nichols Institute, 14225 Newbrook Drive, Chantilly, VA 20151, USA
    Cancer Genet Cytogenet 191:43-5. 2009
  3. ncbi Cytogenetics and genetics of human cancer: methods and accomplishments
    Avery A Sandberg
    Cancer Genet Cytogenet 203:102-26. 2010
  4. ncbi Variant acute promyelocytic leukemia translocation (15;17) originating from two subsequent balanced translocations involving the same chromosomes 15 and 17 while preserving the PML/RARA fusion
    Carlos A Tirado
    Laboratory of Cytogenetics, Quest Diagnostics Nichols Institute, 14225 Newbrook Drive, Chantilly, VA 20151, USA
    Cancer Genet Cytogenet 161:70-3. 2005
  5. ncbi Dicentric (17;20)(p11.2;q11.2): an uncommon cytogenetic abnormality in myeloid malignancies
    Carlos A Tirado
    Laboratory of Cytogenetics, Quest Diagnostics Nichols Institute, 14225 Newbrook Drive, Chantilly, VA 20151, USA
    Cancer Genet Cytogenet 170:61-4. 2006
  6. ncbi Insertion (12;9)(p13;q34q34): a cryptic rearrangement involving ABL1/ETV6 fusion in a patient with Philadelphia-negative chronic myeloid leukemia
    Joann C Kelly
    Cytogenetics Department, Quest Diagnostics Nichols Institute, Chantilly, VA 20151, USA
    Cancer Genet Cytogenet 192:36-9. 2009
  7. ncbi Exon scanning by reverse transcriptase-polymerase chain reaction for detection of known and novel EML4-ALK fusion variants in non-small cell lung cancer
    Heather R Sanders
    Department of Hematology and Oncology, Quest Diagnostics Nichols Institute, San Juan Capistrano, CA, USA
    Cancer Genet 204:45-52. 2011
  8. ncbi Commentary on ISCN 2005
    Aurelia M Meloni-Ehrig
    Cancer Genet Cytogenet 175:89-90. 2007

Detail Information

Publications8

  1. ncbi Isolated del(14)(q21) in a case of precursor B-cell acute lymphoblastic leukemia
    Aurelia M Meloni-Ehrig
    Laboratory of Cytogenetics, Quest Diagnostics Nichols Institute, 14225 Newbrook Drive, Chantilly, VA 20151, USA
    Cancer Genet Cytogenet 161:82-5. 2005
    ..Fluorescence in situ hybridization performed using the probes TEL/AML1 and immunoglobulin heavy chain (IGH) showed no fusion involving the TEL and AML1 genes and only a single IGH signal in 20% of the interphase cells analyzed...
  2. ncbi Translocation (2;8)(q35;q13): a recurrent abnormality in congenital embryonal rhabdomyosarcoma
    Aurelia Meloni-Ehrig
    Department of Cytogenetics, Quest Diagnostics Nichols Institute, 14225 Newbrook Drive, Chantilly, VA 20151, USA
    Cancer Genet Cytogenet 191:43-5. 2009
    ..We postulate that the t(2;8)(q35;q13) is a specific abnormality in congenital ERMS, and that it involves the PAX3 gene at 2q35 and a non-yet identified gene at 8q13...
  3. ncbi Cytogenetics and genetics of human cancer: methods and accomplishments
    Avery A Sandberg
    Cancer Genet Cytogenet 203:102-26. 2010
    ..We also look at a few of the more recent genomic developments in cancer and offer an opinion as to what all these findings add up to...
  4. ncbi Variant acute promyelocytic leukemia translocation (15;17) originating from two subsequent balanced translocations involving the same chromosomes 15 and 17 while preserving the PML/RARA fusion
    Carlos A Tirado
    Laboratory of Cytogenetics, Quest Diagnostics Nichols Institute, 14225 Newbrook Drive, Chantilly, VA 20151, USA
    Cancer Genet Cytogenet 161:70-3. 2005
    ....
  5. ncbi Dicentric (17;20)(p11.2;q11.2): an uncommon cytogenetic abnormality in myeloid malignancies
    Carlos A Tirado
    Laboratory of Cytogenetics, Quest Diagnostics Nichols Institute, 14225 Newbrook Drive, Chantilly, VA 20151, USA
    Cancer Genet Cytogenet 170:61-4. 2006
    ..The key mechanism might be the loss of TP53 as well as other tumor suppressor genes in 20q that may have a critical role in tumor genesis...
  6. ncbi Insertion (12;9)(p13;q34q34): a cryptic rearrangement involving ABL1/ETV6 fusion in a patient with Philadelphia-negative chronic myeloid leukemia
    Joann C Kelly
    Cytogenetics Department, Quest Diagnostics Nichols Institute, Chantilly, VA 20151, USA
    Cancer Genet Cytogenet 192:36-9. 2009
    ..CML patients with an ABL1/ETV6 fusion historically have demonstrated a variable and sometimes transient response to treatment with imatinib mesylate, which was also the case in the present patient...
  7. ncbi Exon scanning by reverse transcriptase-polymerase chain reaction for detection of known and novel EML4-ALK fusion variants in non-small cell lung cancer
    Heather R Sanders
    Department of Hematology and Oncology, Quest Diagnostics Nichols Institute, San Juan Capistrano, CA, USA
    Cancer Genet 204:45-52. 2011
    ..This RT-PCR-based exon scanning approach avoids the limitations of screening only for previously identified EML4-ALK fusions and provides a simple molecular assay for fusion detection in a clinical diagnostics setting...
  8. ncbi Commentary on ISCN 2005
    Aurelia M Meloni-Ehrig
    Cancer Genet Cytogenet 175:89-90. 2007